Skip to content Skip to footer
Subscribe Now
Viewpoint_Patricia_Mae_Doykos
VIEWPOINTS
PharmaShots Interview: BMS Foundation’s Patricia Mae Doykos Shares Insights on COVID Advocacy Exchange
In a recent interview with PharmaShots, Patricia Mae Doykos, Lead, Health Equity Initiative, and Director, BMS Foundation at Bristol Myers Squibb shared her views on the promotion of health equity and improvement in health outcomes of populations disproportionately affected by serious diseases and conditions. Shots: CAE is a virtual platform that convenes advocacy groups, patients, and industry to…
January 27, 20210Comments
Viewpoint_Dr. Michael_Shepard_2021
VIEWPOINTS
PharmaShots Interview: Enosi LifeSciences’ Dr. H. Michael Shepard Shares Insights on TNF-Inhibiting Molecules
In a recent interview with PharmaShots, Dr. H. Michael Shepard CEO and Co-Founder of Enosi shared his views on the announcement that Enosi Life Sciences has filed a patent for three of its TNF-inhibiting molecules: EN1001 for autoimmune disease, along with EN2001 and EN3001 for autoimmune disease and cancer. Shots: Enosi will offer use in multiple diseases and…
January 27, 20210Comments
Exclusive Coverage Key Takeaways from the Webinar on HEOR HTA - The Evolving Role in the Indian Healthcare Ecosystem
EVENTS
Exclusive Coverage: Key Takeaways from the Webinar on HEOR/ HTA – The Evolving Role in the Indian Healthcare Ecosystem
Intellimed Healthcare Solutions organized an online webinar on 'Health Economics and Outcomes Research/ Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem' on 15th January 2021. The objective was to gain insights into the current scenario and the need for HEOR/HTA in India. Health economics and outcomes research (HEOR) is a growing field that provides…
January 21, 20210Comments
Viewpoint_Jonas_Duss_2021
VIEWPOINTS
PharmaShots Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App
In a recent interview with PharmaShots, Jonas Duss, US CEO and Co-Founder at Kaia Health shared his views on the Kaia Health's COPD Pulmonary Rehabilitation App and their collaboration with Chiesi Group to commercialize the app in EU. Shots: Kaia Health signs an exclusive agreement with Chiesi Group to commercialize the Kaia Health COPD Pulmonary Rehabilitation…
January 19, 20210Comments
Viewpoint_Dr.Jing_Watnick_&_Dr. Lou_Vaickus_2021
VIEWPOINTS
PharmaShots Interview: Vigeo Therapeutics’ Dr. Lou Vaickus and Dr. Jing Watnick Share Insights on VT1021 Data Presented at SITC 2020
In a recent interview with PharmaShots, Dr. Jing Watnick, Co-Founder and Chief Executive Officer, and Dr. Lou Vaickus, Interim Chief Medical Officer at Vigeo shared their views on the data findings presented at the SITC 2020 Annual Meeting that demonstrated VT1021 as a single-agent has a favorable safety profile and shows early signals of clinical activity across a wide variety of…
January 15, 20210Comments

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]